Rockefeller Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Rockefeller Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$614K	Sell	42,384 -5,228	-11%	-$70.5K	﹤0.01%	1982
2026 Q1	$659K	Buy	47,612 +45,565	+2,226%	+$634K	﹤0.01%	1814
2025 Q4	$28.7K	Buy	2,047 +821	+67%	+$11.5K	﹤0.01%	3342
2025 Q3	$17.1K	Buy	+1,226	New	+$17.6K	﹤0.01%	3418
2024 Q2	–	Sell	-54,690	Closed	-$802K	–	1713
2024 Q1	$802K	Sell	54,690 -28,590	-34%	-$417K	﹤0.01%	1331
2023 Q4	$1.16M	Buy	+83,280	New	+$1.11M	﹤0.01%	1086
2023 Q1	–	Sell	-200	Closed	-$2K	–	3477
2022 Q4	$2K	Hold	200	–	–	﹤0.01%	3601
2022 Q3	$2K	Sell	200 -655	-77%	-$6.98K	﹤0.01%	3619
2022 Q2	$9K	Buy	+855	New	+$9.3K	﹤0.01%	3189
2022 Q1	–	Sell	-150	Closed	-$1K	–	4033
2021 Q4	$1K	Sell	150 -70	-32%	-$882	﹤0.01%	3682
2021 Q3	$2K	Buy	220 +145	+193%	+$1.93K	﹤0.01%	3472
2021 Q2	$1K	Sell	75 -720	-91%	-$10.1K	﹤0.01%	3374
2021 Q1	$9K	Buy	+795	New	+$10.2K	﹤0.01%	2650
2020 Q4	–	Sell	-920	Closed	-$12K	–	2985
2020 Q3	$12K	Buy	+920	New	+$11K	﹤0.01%	1966
2019 Q4	–	Sell	-450	Closed	-$3K	–	2175
2019 Q3	$3K	Hold	450	–	–	﹤0.01%	1740
2019 Q2	$3K	Buy	+450	New	+$3.54K	﹤0.01%	1513

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Rockefeller Capital Management's RDY Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Dr. Reddy's Laboratories (RDY) stake by 11% in Q2 2026, selling an estimated $70.5K and leaving 42,384 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Rockefeller Capital Management first reported a position in RDY in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.16M in Q4 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Rockefeller Capital Management held 42,384 shares of Dr. Reddy's Laboratories worth $614K as of Q2 2026.
Rockefeller Capital Management sold 5,228 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $70.5K.
Dr. Reddy's Laboratories made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1982 holding.
Rockefeller Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2019 and has held it in 16 quarters since.
Rockefeller Capital Management's Dr. Reddy's Laboratories position peaked at $1.16M in Q4 2023.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.